透过“看病贵”现象,我们不难看到医疗费用长期快速增长背后药价失控的现实困局。众所周知,多年来控制“药占比”和实施“基药制度”等改革措施,效果一直不佳,某种程度还推涨了检验检测费用和材料费用。行政部门主导砍药价和统一招标,也没有真正降低总药费,反而造成愈加严重的药价畸形格局。为什么?医务人员劳务价格长期普遍严重偏低和技术价值被忽视,是深层 It is not hard to see the real dilemma behind the long-term rapid growth of medical costs that drug prices are out of control. It is known to all that reform measures such as controlling the proportion of medicine and implementing the system of drug-based medicine over the years have been ineffective and have, to some extent, pushed up testing and testing costs and material costs. Administrative departments dominate the cut drug prices and uniform bidding, but also did not really reduce the total drug costs, but the result is even more serious pattern of abnormal drug prices. Why? Medical staff labor prices are generally serious low long-term and technical value is neglected, is deep